Question explored with the scientific record
What does study suggest. Is there a link between Metformin and B12 deficiency ?
The short version: the evidence is clear that metformin causes vitamin B12 deficiency in a substantial fraction of users, and the official label understates the risk.
The link between metformin and B12 deficiency is one of the better-documented adverse drug effects in diabetes care. A 2024 meta-analysis found that metformin use is associated with decreased B12 concentrations across exposure durations from 6 weeks to 48 months, with reported deficiency rates ranging from 6.3% to 35% [1]. That same review explicitly states the prevalence is greater than what is declared on the regulatory Summary of Product Characteristics [1]. A 2010 BMJ randomized placebo-controlled trial—one of the strongest designs available—found that after long-term treatment, 9.9% of metformin users developed B12 deficiency versus 2.7% on placebo [9]. A 2014 meta-analysis of 29 studies covering 8,089 patients calculated an odds ratio of 2.45 for B12 deficiency with metformin use [3].
The risk is dose-dependent and time-dependent. A 2026 Ugandan study found that a dose of 2000 mg/day carried an adjusted odds ratio of 4.63 for deficiency, and use for 10 years or more carried an aOR of 4.04 [5]. A 2016 Indian study showed mean B12 levels dropping from 183 pg/mL in those taking under 1500 mg to 118 pg/mL in those taking 1500 mg or more, and from 163 pg/mL in those using metformin under 5 years to 101 pg/mL in those using it 5 years or longer [6]. A Ghanaian cross-sectional study found a combined B12 deficiency prevalence of 14.3% using both serum B12 and methylmalonic acid, with longer duration and higher dose as significant risk factors [4].
The mechanism is not speculative. A 1983 study directly demonstrated malabsorption of B12 during metformin therapy, with absorption improving after drug withdrawal [8]. The deficiency is not just a lab finding. The 2026 Ugandan study linked B12 deficiency to higher rates of peripheral neuropathy and neuropsychiatric symptoms [5]. A 2007 case report documented a 65-year-old woman on long-term metformin who developed deep vein thrombosis associated with B12 deficiency and elevated homocysteine, which improved after stopping metformin and starting B12 [2].
The good news is that the deficiency is treatable. A 2025 randomized study found that oral methylcobalamin 1000 mcg daily was as effective as intramuscular injections for restoring B12 levels in metformin-treated patients [7].
| Group | B12 deficiency prevalence | Key risk factors |
|---|---|---|
| Metformin users (BMJ 2010 RCT) | 9.9% vs 2.7% placebo | Long-term use |
| Metformin users (NHANES 2012, age 50+) | 5.8% vs 2.4% non-users | Age, diabetes status |
| Metformin users (Ghana 2019) | 14.3% (combined criteria) | Dose, duration, body fat |
| Metformin users (Uganda 2026) | 10.1% | Dose 2000 mg/day, duration 10+ years |
| Metformin users (meta-analysis range) | 6.3% to 35% | Varies by study and definition |
My call: metformin clearly causes B12 deficiency in a dose- and duration-dependent manner, at rates higher than the label states, and this deficiency can cause real harm including neuropathy and elevated homocysteine. Anyone on metformin should have their B12 checked regularly and should supplement if deficient. Confidence: high.
Sources used 9
-
Metformin and vitamin B12 deficiency: What is the evidence?
This meta-analysis review found that metformin use is associated with decreased vitamin B12 concentrations and a higher prevalence of vitamin B12 deficiency than stated in regulatory product characteristics, with reductions from 6.3% to 35%.
DOI: 10.5937/scriptamed55-48795 -
Hyperhomocysteinemia, Deep Vein Thrombosis and Vitamin B12 Deficiency in a Metformin-treated Diabetic Patient
A case study of a 65-year-old Taiwanese woman with type 2 diabetes on long-term metformin developes deep vein thrombosis associated with metformin-induced vitamin B12 deficiency and MTHFR C677T homozygosity, with improvement after stopping metformin, B12 supplementation, and ant…
DOI: 10.1016/s0929-6646(08)60039-x -
The role of metformin on vitamin B12 deficiency: a meta-analysis review
This meta-analysis review investigates the association between metformin treatment and vitamin B12 deficiency, concluding that metformin significantly increases the incidence of B12 deficiency and reduces serum B12 levels in patients with type 2 diabetes mellitus.
DOI: 10.1007/s11739-014-1157-5 -
Vitamin B 12 deficiency in type 2 diabetic patients on metformin: a cross-sectional study from South-Western part of Ghana
A cross-sectional study in Ghanaian type 2 diabetics on metformin to determine the prevalence of vitamin B12 deficiency using serum B12 and methylmalonic acid (MMA) measurements and to identify associated risk factors such as metformin dose, duration, and body fat.
DOI: 10.1080/20905068.2019.1662647 -
Evaluation of Vitamin B12 Deficiency Among Patients with Type 2 Diabetes Mellitus on Metformin at Hoima Regional Referral Hospital, Uganda
Among Ugandan adults with type 2 diabetes on metformin at Hoima Regional Referral Hospital, vitamin B12 deficiency occurred in 10.1% and was independently linked to higher metformin dose (2000 mg/day), longer duration of therapy (≥10 years), and poor glycemic control, with defic…
DOI: 10.2147/DMSO.S562440 -
Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes?
In metformin-treated Type 2 diabetes patients, Vitamin B12 deficiency was common and worsened with higher dose and longer duration, but this deficiency did not account for cognitive impairment measured by event-related potentials, suggesting other diabetes-related factors underl…
DOI: 10.4103/0253-7176.185952 -
MON-520 Comparison of Oral and Intramuscular Vitamin B12 Supplementation in Metformin-Treated Diabetes Mellitus Patients With Vitamin B12 Deficiency
In metformin-treated type 2 diabetes patients with vitamin B12 deficiency, this randomized study compared oral methylcobalamin 1000 mcg daily versus intramuscular 1000 mcg weekly (followed by quarterly dosing) for 6 months, finding no difference in B12 restoration and concluding…
DOI: 10.1210/jendso/bvaf149.887 -
Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy
This study investigates the malabsorption of vitamin B12 in diabetic patients undergoing biguanide therapy, revealing that 30% of patients experienced malabsorption, with varying responses to drug withdrawal and intrinsic factor supplementation.
DOI: 10.1007/BF00275941 -
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
This study demonstrates that long-term treatment with metformin in patients with type 2 diabetes significantly increases the risk of vitamin B-12 deficiency and raises homocysteine levels, highlighting the need for regular monitoring of vitamin B-12 during treatment.
DOI: 10.1136/bmj.c2181